MIRA INFORM REPORT

 

 

Report Date :

30.04.2013

 

IDENTIFICATION DETAILS

 

Name :

SHIN NIPPON YAKUGYO CO LTD

 

 

Registered Office :

11-9 Nihombashi-Tomizawacho Chuoku Tokyo 103-0006

 

 

Country :

Japan

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

April 1951

 

 

Legal Form :

Limited Company (Kabushiki Kaisha)

 

 

Line of Business :

Import, export, wholesale of pharmaceuticals, cosmetics, chemicals, other

 

 

No. of Employees :

43

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 


COMPANY NAME AND ADDRESS

 

SHIN NIPPON YAKUGYO CO LTD

REGD NAME:   Shin Nippon Yakugyo KK

MAIN OFFICE:  11-9 Nihombashi-Tomizawacho Chuoku Tokyo 103-0006 JAPAN

Tel: 03-3667-5941     Fax: 03-3667-5944

 

URL:                 http://www.snyjapan.co.jp

E-mail Address:            (thru the URL)   

 

ACTIVITIES:     Import, export, wholesale of pharmaceuticals, cosmetics, chemicals, other

BRANCHES:     Osaka

 

OFFICER(S):     HIDEO TSUNODA, PRES          Koichiro Tsunoda, mgn dir

                        Natsuhiko Hanada, dir                Kiyokazu Kashihara, dir

                        Masatake Yoshida, dir               Masayo Fujimoto, dir

 

Yen Amount:     In million Yen, unless otherwise stated

 

SUMMARY:      FINANCES        FAIR                 A/SALES          Yen 7,956 M

                        PAYMENTS      REGULAR         CAPITAL           Yen 80 M

                        TREND             STEADY           WORTH                        Yen 2,697 M

                        STARTED         1951                 EMPLOYES      43

                                                                       

COMMENT:      TRADING FIRM SPECIALIZING IN PHARMACEUTICALS, CHEMICALS,

COSMETICS, OTHER. 

FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY BUSINESS ENGAGEMENTS

 

                        MAX CREDIT LIMIT: YEN 259.8 MILLION, 30 DAYS NORMAL TERMS. 

                       

 

HIGHLIGHTS:

           

            The subject company was established by a certain Tsunoda in order to make most of his experience in the subject line of business.  The firm has been succeeded by his descendants.  This is a trading firm specializing in import, export and wholesale of: pharmaceuticals products, medical products for animals, agricultural chemicals, cosmetics, other (See OPERATION).  Clients include major pharmaceutical makers nationwide.

 

 

FINANCIAL INFORMATION:

 

            The sales volume for Mar 2012 fiscal term amounted to Yen 7,956 million, a 13% up from Yen 7,037 million in the previous term.  The recurring profit was posted at Yen 105 million and the net profit at Yen 120 million, respectively, compared with Yen 165 million recurring profit and Yen 28 million net profit, respectively, a year ago.

  .

For the term ended Mar 2013 the recurring profit was projected at Yen 110 million and the net profit at Yen 130 million, respectively, on a 5% rise in turnover, to Yen 8,350 million.  Final results are yet to be released.

 

            The financial situation is considered FAIR and good for ORDINARY business engagements.  Max credit limit is estimated at Yen 259.8 million, on 30 days normal terms. 

 

 

REGISTRATION

 

            Date Registered:  Apr 1951

            Legal Status:     Limited Company (Kabushiki Kaisha)

            Authorized:       6.4 million shares

            Issued:              1.6 million shares

            Sum:                 Yen 80 million

            Major shareholders (%): Koichiro Tsunoda (21), Hideo Tsunoda (16), Keiji Yoshida (14),

            Employees’ S/Holding Assn (10), Noriko Nachigami (8)

            No. of shareholders: 23

           

           Nothing detrimental is known as to the commercial morality of executives.

 

 

OPERATION:

 

Activities: Imports, exports and wholesales: pharmaceuticals, medicated cosmetics, cosmetics, medical devices, veterinary medicines, agricultural chemicals, reagents, diagnostic agents, chemicals, food products, food additives, animal feeds, other (--100%)

 

Clients: [Mfrs, wholesalers] Nichi-Iko Pharmaceutical Co, Mitsubishi Tanabe Pharma Corp, Yakult Honsha, Aska Pharmaceutical Co, Hisamitsu Pharmaceutical, Towa Pharmaceutical Co, Taisho Pharmaceutical, Kobayashi Kako Co, Zensei Pharmaceutical Ind, Seiko Eiyo Yakuhin Co, other

            No. of accounts: 500

            Domestic areas of activities: Nationwide

Suppliers: [Mfrs, wholesalers] New Zealand Pharmaceutical, Kanematsu GmbH, MIAT Spa, Yuhan Corp, Nichi-Iko Pharmaceutical, Nippon Carbide Ind, Seiko Eiyo Yakuhin, Konoshima Chemical Co, other.

 

Payment record: Regular

 

Location: Business area in Tokyo.  Office premises at the caption address are leased and maintained satisfactorily.

 

            Bank References:

                        MUFG (Nihombashi-Chuo)

                        Mizuho Bank (Nihombashi)

                        Relations: Satisfactory

 

 

FINANCES

(In Million Yen)

 

       Terms Ending:

31/03/2013

31/03/2012

31/03/2011

31/03/2010

Annual Sales

 

8,350

7,956

7,037

6,557

Recur. Profit

 

110

105

16

195

Net Profit

 

130

120

28

82

Total Assets

 

 

6,361

6,487

6,186

Current Assets

 

 

3,235

3,608

3,344

Current Liabs

 

 

2,940

3,033

2,719

Net Worth

 

 

2,697

2,664

2,663

Capital, Paid-Up

 

 

80

80

80

Div.P.Share(¥)

 

 

 

 

 

<Analytical Data>

(%)

(%)

(%)

(%)

    S.Growth Rate

4.95

13.06

7.32

3.95

    Current Ratio

 

..

110.03

118.96

122.99

    N.Worth Ratio

..

42.40

41.07

43.05

    R.Profit/Sales

 

1.32

1.32

0.23

2.97

    N.Profit/Sales

1.56

1.51

0.40

1.25

    Return On Equity

..

4.45

1.05

3.08

 

Notes: Forecast (or estimated) figures for the 31/03/2013 Fiscal Term.

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.